30Jun
Healthcare M&A prospers, despite fall in deal activity
The megadeals of 2019 may be off the table for now, but deal activity across healthcare and pharmaceuticals has proven resilient through the COVID-19 crisis - Although pharma, medical and biotech (PMB) M&A deal value for Q1 2020 came in at US$39.3 billion, 78% below the year before, this was primarily due to the outsized US$87.8 billion deal between Bristol-Myers Squibb and Celgene in early 2019....
By:
White & Case LLP
Related
Employees or applicants with disabling medical conditions must place the employer on notice of such ...
Read More >
California employers breathed a bit easier once a federal judge pressed the indefinite pause button ...
Read More >
Seyfarth Synopsis: The Cal/OSH Standards Board will vote this week on a proposed standard requiring...
Read More >
Seyfarth Synopsis: A New York appellate court recently held that New York employers may be liable f...
Read More >
As employers scramble to meet the September 30, 2019 deadline to submit pay data for years 2017 and ...
Read More >
Today we honor the US Women’s Soccer team who won their fourth World Cup over the weekend by defeat...
Read More >